Early-Phase Drug Discovery

General Biological Technologies The EPDD service has well-established capabilities for developing cell lines and assays via transient or stable cell transfections and for adapting assays for use in HTS. Assay endpoints can...
Early-Phase Drug Discovery services are provided on a tiered basis. Tier 1: Consultation and Initial Planning 4-10 hours Consists of consulting services designed to inform the researcher of gaps in his or her early-phase...
NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact